Ep. 210 Personalizing ADT Across the Prostate Cancer Spectrum with Dr. Rana McKay

1616.161 - 1634.245 Aditya Bagrodia

And it kind of segues into, so, you know, maybe for finite favorable risk, of course, there's a counseling and it's kind of like, I just got to get through this and you'll be fine. For the higher risk, it's a longer duration. Maybe some of the metabolic elements become a little bit more front and center. And then there's kind of you're in the long haul and, you know, whether that's going to be.